Status:
TERMINATED
RIGHTWHEY - Responders In Gut HealTh Markers Using Fermented WHEY
Lead Sponsor:
University of Aberdeen
Collaborating Sponsors:
A. Vogel
Conditions:
Health, Subjective
Healthy
Eligibility:
All Genders
18-68 years
Phase:
NA
Brief Summary
This 8-week intervention will investigate the effect of daily consumption of a fermented whey concentrate on the short-chain fatty acid profile of faeces in healthy individuals. This study will help ...
Detailed Description
The 8-week dietary supplementation trial will investigate the action of exogenous lactic acid consumption on the activity (using short-chain fatty acid) and composition of the gut microbiota. Partici...
Eligibility Criteria
Inclusion
- i. Men and women aged 18-68 years; BMI ranging from 18-35 kg/m2; measured at the screening visit
Exclusion
- i. smokers
- ii. subjects with: diagnosis of diabetes, pregnant, hypertension, renal, hepatic, haematological disease, coronary heart disease or any gastrointestinal disorder
- ii. unsuitable veins for blood sampling;
- iii. inability to speak, read and understand English.
- iv. Use of antibiotics within the last 3 months will automatically exclude volunteers.
- v. Vegans. Fermented whey concentrate, (FWC), is derived from milk (animal product) which excludes potential participants adhering to a vegan diet.
- vi. allergy to any of the following: cow milk, lactose, casein, whey, sucralose, acesulfame K, citric acid, potassium benzoate, fruit flavourings.
Key Trial Info
Start Date :
March 13 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 8 2020
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT03844152
Start Date
March 13 2019
End Date
April 8 2020
Last Update
November 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Rowett Institute, Human Nutrition Unit
Aberdeen, United Kingdom, AB25 2ZD